Skip to main navigation Skip to search Skip to main content

Treatment with Mountain-Cultivated Ginseng Alleviates Trimethyltin-Induced Cognitive Impairments in Mice via IL-6-Dependent JAK2/STAT3/ERK Signaling

  • Thu Hien Thi Tu
  • , Naveen Sharma
  • , Eun Joo Shin
  • , Hai Quyen Tran
  • , Yu Jeung Lee
  • , Seung Yeol Nah
  • , Hoang Yen Phi Tran
  • , Ji Hoon Jeong
  • , Jung Hwan Jeong
  • , Sung Kwon Ko
  • , Jae Kyung Byun
  • , Hyoung Chun Kim
  • Kangwon National University
  • University of Medicine and Pharmacy at Ho Chi Minh City
  • Chung-Ang University
  • Korea Forestry Promotion Institute
  • Semyung University
  • Korean Society of Forest Environment Research

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Panax ginseng is the most widely used herbal medicine for improving cognitive functions. The pharmacological activity and underlying mechanisms of mountain-cultivated ginseng, however, have yet to be clearly elucidated, in particular, against trimethyltin-induced cognitive dysfunction. We previously reported that interleukin-6 plays a protective role against trimethyltin-induced cognitive dysfunction. Because of this, we have implemented a study system that uses interleukin-6 null (-/-) and wild-type mice. Interestingly, mountain-cultivated ginseng significantly upregulated interleukin-6 expression. With this study, we sought to determine whether the interleukin-6-dependent modulation of the Janus kinase 2/signal transducer activator of transcription 3 and extracellular signal-regulated kinase signaling network is also associated with the pharmacological activity of mountain-cultivated ginseng against trimethyltin-induced cognitive dysfunction. Trimethyltin treatment (2.4 mg/kg, intraperitoneal) causes the downregulation of Janus kinase 2/signal transducer activator of transcription 3, extracellular signal-regulated kinase signaling, and impairment of the cholinergic system. We found that mountain-cultivated ginseng treatment (50 mg/kg, intraperitoneal) significantly attenuated cognitive impairment normally induced by trimethyltin by upregulating p-Janus kinase 2/signal transducer activator of transcription 3, p-extracellular signal-regulated kinase signaling, and the cholinergic system. Trimethyltin-induced cognitive impairments were more pronounced in interleukin-6 (-/-) mice than wild-type mice, and they were markedly reduced by treatment with either mountain-cultivated ginseng or recombinant interleukin-6 protein (6 ng, intracerebroventricular). Additionally, treatment with either AG490 (20 mg/kg, intraperitoneal), a Janus kinase 2/signal transducer activator of transcription 3 inhibitor, or U0126 (2 μg/head, intracerebroventricular), an extracellular signal-regulated kinase inhibitor, reversed the effects of mountain-cultivated ginseng treatment. The effects of mountain-cultivated ginseng treatment were comparable to those of recombinant interleukin-6 protein in interleukin-6 (-/-) mice. Our results, therefore, suggest that mountain-cultivated ginseng acts through interleukin-6-dependent activation of Janus kinase 2/signal transducer activator of transcription 3/extracellular signal-regulated kinase signaling in order to reverse cognitive impairment caused by trimethyltin treatment.

Original languageEnglish
Pages (from-to)1342-1350
Number of pages9
JournalPlanta Medica
Volume83
Issue number17
DOIs
StatePublished - 1 Nov 2017

Keywords

  • Araliaceae
  • cholinergic system
  • cognitive dysfunction
  • IL-6 knockout mice
  • JAK2/STAT3/ERK signaling
  • Panax ginseng
  • trimethyltin

Fingerprint

Dive into the research topics of 'Treatment with Mountain-Cultivated Ginseng Alleviates Trimethyltin-Induced Cognitive Impairments in Mice via IL-6-Dependent JAK2/STAT3/ERK Signaling'. Together they form a unique fingerprint.

Cite this